RT Journal Article
SR Electronic
T1 897-B A <em>DNAJB1-PRKACA</em> fusion peptide vaccine combined with ipilimumab and nivolumab elicits polyclonal fusion-specific T cell responses in fibrolamellar carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1820
OP A1820
DO 10.1136/jitc-2023-SITC2023.0897-B
VO 11
IS Suppl 2
A1 Kirk, Allison M
A1 Crawford, Jeremy C
A1 Kamdar, Zeal
A1 Baretti, Marina
A1 Yarchoan, Mark
A1 Thomas, Paul G
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1820.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.